Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Smits

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
JCI Insight|May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymusKirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Haematologica|April 12, 2012
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemiaLinda Zuurbier, Emanuel F Petricoin, Maartje J Vuerhard, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
Haematologica|August 27, 2013
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptorsLinda Zuurbier, Alejandro Gutierrez, Charles G Mullighan, et al.
Leukemia|September 24, 2010
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsL Zuurbier, I Homminga, V Calvert, et al.
Blood|June 7, 2014
PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination eventsRui D Mendes, Leonor M Sarmento, Kirsten Canté-Barrett, et al.
Haematologica|January 11, 2024
The role of the mineralocorticoid receptor in steroidinduced cytotoxicity in pediatric acute lymphoblastic leukemiaAnnelienke M Van Hulst, Jordy C G Van der Zwet, Jessica G C A M Buijs-Gladdines, et al.
JCI Insight|March 10, 2026
Epithelial SLPI Expression In Severe Inflammatory Bowel Disease Relates to High IL-17 and Neutrophil ProgrammingSandrine Nugteren, Beatriz Calado, Ytje Simons-Oosterhuis, et al.
Plos Medicine|December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyYunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Leukemia|May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
JCI Insight|May 10, 2022
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymusKirsten Canté-Barrett, Mariska T Meijer, Valentina Cordo', et al.
Haematologica|April 12, 2012
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemiaLinda Zuurbier, Emanuel F Petricoin, Maartje J Vuerhard, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
Haematologica|August 27, 2013
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptorsLinda Zuurbier, Alejandro Gutierrez, Charles G Mullighan, et al.
Leukemia|September 24, 2010
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsL Zuurbier, I Homminga, V Calvert, et al.
Blood|June 7, 2014
PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination eventsRui D Mendes, Leonor M Sarmento, Kirsten Canté-Barrett, et al.
Haematologica|January 11, 2024
The role of the mineralocorticoid receptor in steroidinduced cytotoxicity in pediatric acute lymphoblastic leukemiaAnnelienke M Van Hulst, Jordy C G Van der Zwet, Jessica G C A M Buijs-Gladdines, et al.
JCI Insight|March 10, 2026
Epithelial SLPI Expression In Severe Inflammatory Bowel Disease Relates to High IL-17 and Neutrophil ProgrammingSandrine Nugteren, Beatriz Calado, Ytje Simons-Oosterhuis, et al.
Plos Medicine|December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyYunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Leukemia|May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.
Pageof 7